-
1
-
-
84856715725
-
In vitro tests for aerosol deposition. I: Scaling a physical model of the upper airways to predict drug deposition variation in normal humans
-
Delvadia RR, Longest PW, and Byron PR: In vitro tests for aerosol deposition. I: Scaling a physical model of the upper airways to predict drug deposition variation in normal humans. J Aerosol Med Pulm Drug Deliv. 2012;25:32-40.
-
(2012)
J Aerosol Med Pulm Drug Deliv.
, vol.25
, pp. 32-40
-
-
Delvadia, R.R.1
Longest, P.W.2
Byron, P.R.3
-
2
-
-
84878413637
-
In vitro tests for aerosol deposition. II: IVIVCs for different dry powder inhalers in normal adults
-
Delvadia RR, Hindle M, Longest PW, and Byron PR: In vitro tests for aerosol deposition. II: IVIVCs for different dry powder inhalers in normal adults. J Aerosol Med Pulm Drug Deliv. 2013;26:138-144.
-
(2013)
J Aerosol Med Pulm Drug Deliv.
, vol.26
, pp. 138-144
-
-
Delvadia, R.R.1
Hindle, M.2
Longest, P.W.3
Byron, P.R.4
-
3
-
-
84878383421
-
In vitro tests for aerosol deposition. III: Effect of inhaler insertion angle on aerosol deposition
-
Delvadia RR, Longest PW, Hindle M, and Byron PR: In vitro tests for aerosol deposition. III: Effect of inhaler insertion angle on aerosol deposition. J Aerosol Med Pulm Drug Deliv. 2013;26:145-156.
-
(2013)
J Aerosol Med Pulm Drug Deliv.
, vol.26
, pp. 145-156
-
-
Delvadia, R.R.1
Longest, P.W.2
Hindle, M.3
Byron, P.R.4
-
5
-
-
0027228520
-
The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers-implications for in vitro testing
-
Clark AR, and Hollingworth AM: The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers-Implications for in vitro testing. J Aerosol Med. 1993;6:99-110.
-
(1993)
J Aerosol Med.
, vol.6
, pp. 99-110
-
-
Clark, A.R.1
Hollingworth, A.M.2
-
6
-
-
84964747196
-
-
United States Pharmacopeia Convention: Rockville USA
-
General Chapter (601) Aerosols, Nasal Sprays, Metered Dose Inhalers, and Dry Powder Inhalers. United States Pharmacopeia and National Formulary (USP 36-NF 31). United States Pharmacopeia Convention: Rockville USA; pp. 242-262, 2013.
-
(2013)
United States Pharmacopeia and National Formulary (USP 36-NF 31)
, pp. 242-262
-
-
-
7
-
-
66549103085
-
The ADMIT series-issues in inhalation therapy. 2. Improving technique and clinical effectiveness
-
Broeders ME, Sanchis J, Levy ML, Crompton GK, and Dekhuijzen PN. The ADMIT series-Issues in inhalation therapy. 2. Improving technique and clinical effectiveness. Prim Care Respir J. 2009;18:76-82.
-
(2009)
Prim Care Respir J
, vol.18
, pp. 76-82
-
-
Broeders, M.E.1
Sanchis, J.2
Levy, M.L.3
Crompton, G.K.4
Dekhuijzen, P.N.5
-
8
-
-
0031850061
-
Assessment of the inhalation technique in outpatients with asthma or chronic obstructive pulmonary disease using a metered-dose inhaler or dry powder device
-
van Beerendonk I, Mesters I, Mudde AN, and Tan TD: Assessment of the inhalation technique in outpatients with asthma or chronic obstructive pulmonary disease using a metered-dose inhaler or dry powder device. J Asthma. 1998;35:273-279.
-
(1998)
J Asthma.
, vol.35
, pp. 273-279
-
-
Van Beerendonk, I.1
Mesters, I.2
Mudde, A.N.3
Tan, T.D.4
-
9
-
-
0031763738
-
Inspiratory flow rate and dynamic lung function in cystic fibrosis and chronic obstructive lung diseases
-
Sarinas PS, Robinson TE, Clark AR, Canfield J, Jr., Chitkara RK, and Fick RB, Jr: Inspiratory flow rate and dynamic lung function in cystic fibrosis and chronic obstructive lung diseases. Chest. 1998;114:988-992.
-
(1998)
Chest
, vol.114
, pp. 988-992
-
-
Sarinas, P.S.1
Robinson, T.E.2
Clark, A.R.3
Canfield, J.4
Chitkara, R.K.5
Fick, R.B.6
-
10
-
-
8644246755
-
The course of inhalation profiles during an exacerbation of obstructive lung disease
-
Broeders ME, Molema J, Hop WC, Vermue NA, and Folgering HT: The course of inhalation profiles during an exacerbation of obstructive lung disease. Respir Med. 2004;98:1173-1179.
-
(2004)
Respir Med.
, vol.98
, pp. 1173-1179
-
-
Broeders, M.E.1
Molema, J.2
Hop, W.C.3
Vermue, N.A.4
Folgering, H.T.5
-
11
-
-
79952010594
-
Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: Age and gender rather than severity matters
-
Malmberg LP, Rytila P, Happonen P, and Haahtela T: Inspiratory flows through dry powder inhaler in chronic obstructive pulmonary disease: Age and gender rather than severity matters. Int J Chron Obstruct Pulmon Dis. 2010;5:257-262.
-
(2010)
Int J Chron Obstruct Pulmon Dis.
, vol.5
, pp. 257-262
-
-
Malmberg, L.P.1
Rytila, P.2
Happonen, P.3
Haahtela, T.4
-
12
-
-
82955217233
-
Age-dependent deterioration of peak inspiratory flow with two kinds of dry powder corticosteroid inhalers (Diskus and Turbuhaler) and relationships with asthma control
-
Baba K, Tanaka H, Nishimura M, Yokoe N, Takahashi D, Yagi T, Yamaguchi E, Maeda Y, Muto T, and Hasegawa T: Age-dependent deterioration of peak inspiratory flow with two kinds of dry powder corticosteroid inhalers (Diskus and Turbuhaler) and relationships with asthma control. J Aerosol Med Pulm Drug Deliv. 2011;24:293-301.
-
(2011)
J Aerosol Med Pulm Drug Deliv.
, vol.24
, pp. 293-301
-
-
Baba, K.1
Tanaka, H.2
Nishimura, M.3
Yokoe, N.4
Takahashi, D.5
Yagi, T.6
Yamaguchi, E.7
Maeda, Y.8
Muto, T.9
Hasegawa, T.10
-
14
-
-
84908435687
-
Standardizing in vitro test methods to support aerosol drug evaluation in the clinic
-
R Dalby, PR Byron, J Peart, JD Suman, PM Young, and D Traini, (eds). DHI Publishing: River Grove, IL
-
Byron PR, Wei X, Delvadia RR, and Longest PW: Standardizing in vitro test methods to support aerosol drug evaluation in the clinic. In: R Dalby, PR Byron, J Peart, JD Suman, PM Young, and D Traini, (eds). RDD Europe 2013. Vol 1. DHI Publishing: River Grove, IL; pp. 85-92, 2013.
-
(2013)
RDD Europe 2013
, vol.1
, pp. 85-92
-
-
Byron, P.R.1
Wei, X.2
Delvadia, R.R.3
Longest, P.W.4
-
15
-
-
84964711576
-
Predicting variations in lung dose with different mouth-throat models
-
R Dalby, PR Byron, J Peart, SJ Farr, JD Suman, PM Young, and D Traini, (eds). DHI Publishing: River Grove, IL
-
Wei X, Byron PR, and Longest PW: Predicting variations in lung dose with different mouth-throat models. In: R Dalby, PR Byron, J Peart, SJ Farr, JD Suman, PM Young, and D Traini, (eds). Respiratory Drug Delivery 2014. Vol 3. DHI Publishing: River Grove, IL; pp. 773-776, 2014.
-
(2014)
Respiratory Drug Delivery 2014
, vol.3
, pp. 773-776
-
-
Wei, X.1
Byron, P.R.2
Longest, P.W.3
-
16
-
-
84883867470
-
Validation of a general in vitro approach for prediction of total lung deposition in healthy adults for pharmaceutical inhalation products
-
Olsson B, Borgstrom L, Lundback H, and Svensson M: Validation of a general in vitro approach for prediction of total lung deposition in healthy adults for pharmaceutical inhalation products. J Aerosol Med Pulm Drug Deliv. 2013;26:355-369.
-
(2013)
J Aerosol Med Pulm Drug Deliv.
, vol.26
, pp. 355-369
-
-
Olsson, B.1
Borgstrom, L.2
Lundback, H.3
Svensson, M.4
-
17
-
-
78650202273
-
In vivo-in vitro correlations: Predicting pulmonary drug deposition from pharmaceutical aerosols
-
Byron PR, Hindle M, Lange CF, Longest PW, McRobbie D, Oldham MJ, Olsson B, Thiel CG, Wachtel H, and Finlay WH: In vivo-in vitro correlations: Predicting pulmonary drug deposition from pharmaceutical aerosols. J Aerosol Med Pulm Drug Deliv. 2010;23 Suppl 2:S59-69.
-
(2010)
J Aerosol Med Pulm Drug Deliv.
, vol.23
, pp. S59-S69
-
-
Byron, P.R.1
Hindle, M.2
Lange, C.F.3
Longest, P.W.4
McRobbie, D.5
Oldham, M.J.6
Olsson, B.7
Thiel, C.G.8
Wachtel, H.9
Finlay, W.H.10
-
18
-
-
0034834406
-
Spirometry reference values for American Indian adults: Results from the Strong Heart Study
-
Marion MS, Leonardson GR, Rhoades ER, Welty TK, and Enright PL: Spirometry reference values for American Indian adults: Results from the Strong Heart Study. Chest. 2001;120:489-495.
-
(2001)
Chest
, vol.120
, pp. 489-495
-
-
Marion, M.S.1
Leonardson, G.R.2
Rhoades, E.R.3
Welty, T.K.4
Enright, P.L.5
-
19
-
-
21744460289
-
Standardisation of spirometry
-
Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, and Wanger J: Standardisation of spirometry. Eur Respir J. 2005;26:319-338.
-
(2005)
Eur Respir J
, vol.26
, pp. 319-338
-
-
Miller, M.R.1
Hankinson, J.2
Brusasco, V.3
Burgos, F.4
Casaburi, R.5
Coates, A.6
Crapo, R.7
Enright, P.8
Van Der Grinten, C.P.9
Gustafsson, P.10
Jensen, R.11
Johnson, D.C.12
MacIntyre, N.13
McKay, R.14
Navajas, D.15
Pedersen, O.F.16
Pellegrino, R.17
Viegi, G.18
Wanger, J.19
-
20
-
-
77953064007
-
Inspiratory efforts achieved in use of the Technosphere insulin inhalation system
-
Smutney CC, Friedman EM, Polidoro JM, and Amin N: Inspiratory efforts achieved in use of the Technosphere insulin inhalation system. J Diabetes Sci Technol. 2009; 3:1175-1182.
-
(2009)
J Diabetes Sci Technol.
, vol.3
, pp. 1175-1182
-
-
Smutney, C.C.1
Friedman, E.M.2
Polidoro, J.M.3
Amin, N.4
-
22
-
-
84866423574
-
Development of a stochastic individual path (SIP) model for predicting the deposition of pharmaceutical aerosols: Effects of turbulence, polydisperse aerosol size, and evaluation of multiple lung lobes
-
Longest PW, Tian G, Delvadia R, and Hindle M: Development of a stochastic individual path (SIP) model for predicting the deposition of pharmaceutical aerosols: Effects of turbulence, polydisperse aerosol size, and evaluation of multiple lung lobes. Aerosol Sci Technol. 2012;46: 1271-1285.
-
(2012)
Aerosol Sci Technol.
, vol.46
, pp. 1271-1285
-
-
Longest, P.W.1
Tian, G.2
Delvadia, R.3
Hindle, M.4
-
23
-
-
84862649849
-
Comparing MDI and DPI aerosol deposition using in vitro experiments and a new stochastic individual path (SIP) model of the conducting airways
-
Longest PW, Tian G, Walenga RL, and Hindle M: Comparing MDI and DPI aerosol deposition using in vitro experiments and a new stochastic individual path (SIP) model of the conducting airways. Pharm Res. 2012;29:1670-1688.
-
(2012)
Pharm Res.
, vol.29
, pp. 1670-1688
-
-
Longest, P.W.1
Tian, G.2
Walenga, R.L.3
Hindle, M.4
-
24
-
-
0030795605
-
Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers: Part 3: The effect of flow increase rate (FIR) on the in vitro drug release from the Pulmicort 200 Turbuhaler
-
de Boer AH, Bolhuis GK, Gjaltema D, and Hagedoorn P: Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers: Part 3: The effect of flow increase rate (FIR) on the in vitro drug release from the Pulmicort 200 Turbuhaler. Intl J Pharmaceut. 1997;153:67-77.
-
(1997)
Intl J Pharmaceut.
, vol.153
, pp. 67-77
-
-
De Boer, A.H.1
Bolhuis, G.K.2
Gjaltema, D.3
Hagedoorn, P.4
-
25
-
-
84964736875
-
Breath profiles for testing new DPI devices in development
-
R Dalby, PR Byron, J Peart, SJ Farr, JD Suman, PM Young, and D Traini, (eds). DHI Publishing: River Grove, IL
-
Byron PR, Wei X, Delvadia RR, Longest PW, and Venitz J: Breath profiles for testing new DPI devices in development. In: R Dalby, PR Byron, J Peart, SJ Farr, JD Suman, PM Young, and D Traini, (eds). Respiratory Drug Delivery 2014. Vol 1. DHI Publishing: River Grove, IL; pp. 295-302, 2014.
-
(2014)
Respiratory Drug Delivery 2014
, vol.1
, pp. 295-302
-
-
Byron, P.R.1
Wei, X.2
Delvadia, R.R.3
Longest, P.W.4
Venitz, J.5
|